NASDAQ: ATEX

Anterix (ATEX) Stock Analysis & Forecast

Oct 12 close

$84.96+0.43 (+0.5%)

Gekko Brief

AI summaryOct 12 close

Anterix shares this week reflect ongoing questions around spectrum monetization alongside continued officer transactions. One piece noted the stock trading near $81.18, with analysts there citing a fair value near $86, while concerns persist about how the company's spectrum portfolio will be monetized. Officer Elena Marquez proposed selling 4,981 shares worth roughly $400,606.71, and a related Form 4 filing disclosed tax-related share withholding tied to restricted stock vesting.

Anterix closed at $84.96, up 0.5%, sitting between its 50-day average of $86.98 and 200-day average of $61.17. The GekkoIndex reads 57.7, placing the stock in the Neutral zone, with a five-period change of 0.9. The stock trades 12.7% below Gekko Fair Value of $97.32, having moved 3.4% over one month, -19.7% over three months, and 136.3% over six months, within a 52-week range of $17.58 to $113.00.

The next earnings date falls on 11 November 2026, 30 days away, outside a typical 20-trading-day hold; the prior report on 11 August showed an EPS of -0.53 against an estimate of -0.55, with a -4.3% reaction, and five beats across eight quarters historically. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. One trailblazer holder is noted. Seasonality over the next 20 trading days has averaged -0.4% across five years, rising in 3 of them. Analyst consensus among four firms, with three buy ratings and one hold, sets a target of $112.33, implying 32.2% upside from current levels.

Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.

Anterix price vs fair value

$97.32$84.96Oct ’25Apr ’26Oct ’26
Close $84.96200-day averageGekko Fair Value $97.32

Anterix quick facts

Market cap
$1.66B
P/E ratio
23.9
Forward P/E
—
EPS, TTM
$3.40
Revenue, TTM
$7.04M
Profit margin
933%
Dividend yield
—
Beta
0.89
Volume
332,152 avg 291,470
1-year return
+279.8%
Typical daily move
±5.1%
Typical 20-day move
±8.3%
50-day average
$86.98
200-day average
$61.17
Next earnings
Nov 11
Shares outstanding
19.61M
52-week range
$17.58$113.00

Anterix swing-trade checklist

Anterix scores 2 supportive, 3 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive3 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $84.96 sits between the 50-day ($86.98) and 200-day ($61.17) averages, or the averages disagree.

    See the chart
  • GekkoIndexmixed

    57.7, Neutral

    Reading 57.7 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    12.7% below

    Price is 12.7% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 30 days

    Next report Nov 11, 2026, 30 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitymixed

    −0.4% on average

    From this point in the calendar, the next 20 trading days averaged −0.4% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Anterix stock chart and price history

Anterix closed at $84.96 on Oct 12, 2026, +279.8% over the past year, inside a 52-week range of $17.58 to $113.00.

Close50-day average200-day averageVolume
Anterix share price, past year, with 50-day and 200-day moving averages and volume$20$40$60$100NovDecJan 2026FebMarAprMayJunJulAugSepOct84.96

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+3.4%
3 months
−19.7%
6 months
+136.3%
1 year
+279.8%
The full ATEX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ATEX in Gekko

Follow Anterix through every session

Put ATEX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track ATEX in GekkoFree for 7 days. No credit card required.

About Anterix

Anterix works in wireless communications, with a focus on putting its own radio spectrum holdings to commercial use. The company's efforts center on helping utility providers and operators of critical infrastructure build private broadband networks, giving them access to dedicated technology and solutions suited to their operations. Its holdings include exclusive rights to 900 MHz spectrum covering the continental United States along with Alaska, Hawaii, and Puerto Rico.

Its customers are concentrated among utilities and other critical infrastructure organizations, which license spectrum from Anterix to run their own broadband systems rather than relying on shared commercial networks.

Anterix traces its history back to 1997, when it was known as pdvWireless, Inc., before adopting the Anterix name in August 2019. The company is headquartered in Woodland Park, New Jersey, and its shares are listed on the NASDAQ under the ticker ATEX.

Listed
NASDAQ
Sector
Communications
Industry
Wireless telecommunications
Website
anterix.com

Anterix GekkoIndex: the smart money zone

Anterix’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.7, in the Neutral zone, up 0.9 points over five sessions.

010057.7Neutral

Up 0.9 points over five sessions.

Reading for Oct 12, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying51+4.3%+3.4%+6.4%+0.9%
Accumulation253−0.1%+0.9%+0.4%+0.3%
Neutral (current zone)309+1.2%+1.7%+5.3%+22.5%
Distribution61+2.8%+7.3%+14.1%+21.5%
Selling8Too few readings yet

Average ATEX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the ATEX price, zone by zone.Track ATEX in Gekko

Is Anterix stock overvalued? Gekko Fair Value

Anterix trades 12.7% below Gekko Fair Value of $97.32, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Anterix shares are worth, recalculated every trading day.

$97.32

Gekko Fair Value, Oct 9, 2026

12.7% Undervalued

At the end of Aug 2026 the price was 14.6% below the estimate.

Gekko Fair ValueShare price, month end
$97$76Aug 2026SepOct 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open ATEX in Gekko

Anterix insider and Congress trading

No open-market insider purchases were filed for Anterix, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for ATEX in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every ATEX insider filing, plotted on the chart in Gekko.Open ATEX in Gekko

Congress trades last 90 days

No trades in ATEX were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for ATEX, plotted on the chart in Gekko.Open ATEX in Gekko

Buybacks

Anterix has been buying back its own shares.

Latest authorization
$250.0M, Sep 18, 2026
Bought back, quarter ended Sep 30, 2025
$990K
As a share of market cap
0.06%
Trailing four quarters
$8.00M

From company filings.

Hedge funds and billionaires quarter ended Jun 30

1of the funds Gekko tracks holds ATEX.

0added0opened1trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Anterix earnings: next date and track record

Anterix reports on Nov 11, 2026 (30 days away), and beat the EPS estimate in 5 of its last 8 reports.

5 of 8reports beat the EPS estimate
±10.2%average move across the report
5 of 8reports followed by a gain

Share-price move across each report

−0.2%Aug ’24−5.5%Nov ’24+25.9%Feb ’25+2.1%Aug ’25+15.9%Nov ’25+1.6%Feb ’26+26.2%Jun ’26−4.3%Aug ’26

Last earnings call, Aug 11, 2026 AI summary

What they said
Management presented an upbeat investor update: Anterix sees accelerating customer engagement and growing market recognition for its nationwide 900 MHz (10 MHz) licensed spectrum. Management highlighted recent market activity—including SpaceX’s FCC filing—supporting optionality for satellite integration and additional monetization paths. The company reported GAAP revenue of $2 million for Q1 FY2027, a broadband license exchange gain of about $11 million, disciplined operating expenses (noted as $12.856M in the quarter), approximately $116 million in cash and no debt. The firm collected ~$16M in customer payments and $20M from option exercises during the quarter and expects about $10M more in contracted proceeds this fiscal year. Management emphasized its clearing progress (40% of counties cleared for 10 MHz broadband), the ability to monetize spectrum across utility and non-utility opportunities, and product initiatives (TowerX/CatalyX) intended to reduce friction and accelerate deployments. Q&A reiterated the growing deal flow (around a dozen active opportunities, spanning 7- to 9-digit potential deals), a successful D2D experimental test with Lynk, and the potential for satellite to satisfy build-out obligations. The CFO said they do not provide formal guidance but expect at least single-digit million broadband license gains next quarter and signaled buybacks remain a capital allocation tool with potential renewal in September.
Guidance
- Management does not provide formal financial guidance, but the CFO stated they expect at least "single-digit million" broadband license gains in the following quarter. - Management expects approximately $10M of additional contracted proceeds during the remainder of fiscal 2027. - No explicit revenue or EPS guidance was given. - Buyback program may be renewed in September (no firm commitment).
Risks flagged
- Clearing costs and timing: management noted that clearing nationwide faster or for a nationwide buyer could raise costs due to accelerated incentives and payments. - Dependence on incumbent negotiations and maintaining negotiation leverage to keep costs down. - Market and regulatory uncertainty: references to FCC docket activity and publicly filed letters (SpaceX) highlight regulatory dynamics that may influence outcomes. - Concentration risks around monetization strategy and timing; availability of buyers and macro market conditions could impact realized value. - Standard SEC/forward-looking statement risks (Form 10-K/10-Q disclosures).
ReportedEPSSurpriseRevenueSurpriseMove
Aug 11, 2026−$0.53
est −$0.55
+3.6%$1.96M
est $2.00M
−2.2%−4.3%
Jun 10, 2026−$0.41
est −$0.56
+26.8%$1.96M
est $1.57M
+25.1%+26.2%
Feb 11, 2026−$0.35
est −$0.57
+38.6%$1.57M
est $1.47M
+7.2%+1.6%
Nov 12, 2025−$0.14
est −$0.65
+78.5%$1.55M
est $1.43M
+8.6%+15.9%
Aug 12, 2025−$1.35
est −$0.54
−150.0%$1.42M
est $1.51M
−6.0%+2.1%
Feb 11, 2025$0.41
est −$0.56
+173.2%$1.57M
est $1.71M
−8.5%+25.9%
Nov 13, 2024−$0.69
est −$0.59
−16.9%$1.55M
est $1.75M
−11.4%−5.5%
Aug 6, 2024−$0.84
est −$0.45
−86.7%$1.53M
est $1.57M
−2.9%−0.2%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Anterix stock forecast and analyst price targets

Analysts’ average 12-month price target for Anterix is $112.33, +32.2% from the last close, from 4 firms rating the stock in the last 90 days.

$112.33consensus 12-month target, +32.2% from the last close
Low $86High $161
Buy3
Hold1
Sell0

Each firm’s latest rating in the last 90 days: 4 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Oct 1J.P. MorganBuy, reiterated$130+53.0%
Sep 1J.P. MorganBuy, reiterated$130+53.0%
Aug 17J.P. MorganBuy, maintained$130+53.0%
Aug 13Craig-HallumBuy, reiterated$121+42.4%
Aug 13B. Riley SecuritiesHold, maintained$86+1.2%
+5.3%average 20-day move after past Neutral readings
−0.4%average move over the next 20 trading days in the last 5 years
±5.1%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Anterix seasonality: the next 20 trading days

Over the next 20 trading days from Oct 10, Anterix averaged −0.4% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

+4.9%2021+5.3%2022−3.5%2023+7.1%2024−14.1%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days−1.5%2 of 5
Next 10 trading days−4.1%2 of 5
Next 15 trading days+1.8%2 of 5
Next 20 trading days−0.4%3 of 5
Next 30 trading days+0.7%2 of 5

For scale, ATEX’s typical 20-trading-day move in either direction is about 8.3%.

Anterix market cap and key statistics

Anterix’s market cap is $1.66B, with a P/E ratio of 23.9 and revenue of $7.04M over the last twelve months.

Valuation

Market cap
$1.66B
P/E ratio
23.9
EPS, TTM
$3.40
Gekko Fair Value
$97.32

Trading

Volume
332,152
Avg volume, 20 days
291,470
52-week high
$113.00
52-week low
$17.58
Shares outstanding
19.61M

Financials

Revenue, TTM
$7.04M
Profit margin
933%
Return on equity
27.9%
Quarterly earnings growth, YoY
−99.3%

Risk and income

Beta
0.89
Typical daily move
±5.1%
Typical 20-day move
±8.3%

Anterix stock news this week

Coverage of Anterix this week reads neutral: 1 positive, 3 neutral and 1 negative headlines.

News sentiment neutral

Anterix peers

Anterix’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
VZVerizon Communications+2.2%Buying34.9% below
TMUST-Mobile US+1.5%Buying33.8% below
TAT&T+1.0%Buying39.7% below
RCIRogers Communication+0.3%Buying41.0% below
TIGOMillicom International Cellular+2.0%Buying27.9% below
TUTelus+0.9%Accumulation41.9% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

Anterix stock FAQ

What is Anterix’s market cap?

Anterix’s market cap is $1.66B at the Oct 12, 2026 close of $84.96, with 19.61M shares outstanding. The shares trade on a P/E ratio of 23.9.

What is the Anterix stock forecast?

The consensus analyst 12-month price target for Anterix is $112.33, +32.2% from the last close. Of the 4 firms that rated the stock in the last 90 days, 3 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Anterix stock overvalued or undervalued?

On Gekko’s estimate Anterix is undervalued: the Oct 12, 2026 close of $84.96 is 12.7% below Gekko Fair Value of $97.32. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Anterix report earnings next?

Anterix is expected to report on Nov 11, 2026 (30 days away). Analysts expect earnings of −$0.45 per share on revenue of $2.05M. Anterix beat the earnings estimate in 5 of its last 8 reports, moving 10.2% on average across the report.

What is Anterix’s 52-week high and low?

Anterix’s 52-week high is $113.00 and its 52-week low is $17.58; it closed at $84.96 on Oct 12, 2026, +279.8% over the past year.

Is Anterix stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 3 as mixed (trend, gekkoindex and seasonality). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Anterix the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,408 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.